|
English
|
正體中文
|
简体中文
|
2822924
|
|
???header.visitor??? :
30074220
???header.onlineuser??? :
1056
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"crinò l"???jsp.browse.items-by-author.description???
Showing items 11-12 of 12 (1 Page(s) Totally) 1 View [10|25|50] records per page
國立臺灣大學 |
2016 |
Time to response in patients with ALK plus NSCLC receiving alectinib in the phase II NP28673 and NP28761 studies
|
Gandhi, L.; Gadgeel, S.; Shaw, A.; Barlesi, F.; Crino, L.; Yang, J. C-H.; Dingemans, A-M. C.; Kim, D-W.; de Marinis, F.; Schulz, M.; Liu, S.; Fish, S.; Kotb, A.; Ou, S-H. I.; 楊志新 |
國立臺灣大學 |
2012 |
UPDATED RESULTS OF A GLOBAL PHASE II STUDY WITH CRIZOTINIB IN ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC)
|
Kim, D.; Ahn, M.; Yang, P.; Liu, X.; De Pas, T.; Crino, L.; Lanzalone, S.; Polli, A.; Shaw, A. |
Showing items 11-12 of 12 (1 Page(s) Totally) 1 View [10|25|50] records per page
|